Low vitamin D status and obesity: Role of nutritionist

Reviews in Endocrine and Metabolic Disorders

Volumn 18, Issue 2, 2017, Pages 215-225

  Savastano, Silvia ^a   Barrea, Luigi ^b   Savanelli, Maria Cristina ^b   Nappi, Francesca ^b   Di Somma, Carolina ^c   Orio, Francesco ^d   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IOS and COLEMAN Srl   (Italy)

^c IRCCS SDN   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

Diet; Environmental factor; Nutritionist; Obesity; Vitamin D

Indexed keywords

ADIPOCYTOKINE; CALCITRIOL; COLECALCIFEROL; LEPTIN; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; BARIATRIC SURGERY; BODY COMPOSITION; CELL DIFFERENTIATION; DIETARY REFERENCE INTAKE; DIETITIAN; FAT MASS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MEDITERRANEAN DIET; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; PATHOGENESIS; REVIEW; SEDENTARY LIFESTYLE; SUN EXPOSURE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WINTER; ANIMAL; BLOOD; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; METABOLISM; PHYSICIAN ATTITUDE; PHYSIOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DIETARY SUPPLEMENTS; HUMANS; LIPID METABOLISM; NUTRITIONISTS; OBESITY; PHYSICIAN'S ROLE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85013441141     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-017-9410-7     Document Type: Review

References (111)

1. Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: A review. Diabetol Metab Syndr. 2016;10(2):105–12.
2. Looker AC. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab. 2005;90(2):635–40.
3. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham heart study. Diabetes. 2010;59(1):242–8.
4. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, et al. Causal relationship between obesity and vitamin D status: Bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10(2):e1001383.
5. Gangloff A, Bergeron J, Lemieux I, Després JP. Changes in circulating vitamin D levels with loss of adipose tissue. Curr Opin Clin Nutr Metab Care. 2016;19(6):464–70.
6. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89(5):1321–7.
7. Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Hoshiarrad A, Gohari M. Vitamin D3 and the risk of CVD in overweight and obese women: A randomised controlled trial. Br J Nutr. 2012;108(10):1866–73.
8. Yao Y, Zhu L, He L, Duan Y, Liang W, Nie Z, Jin Y, Wu X, Fang Y. A meta-analysis of the relationship between vitamin D deficiency and obesity. Int J Clin Exp Med. 2015;8(9):14977–84.
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
10. Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr. 2012;95(5):1055–9.
11. Mehmood ZH, Papandreou D. An updated mini review of vitamin D and obesity: Adipogenesis and inflammation state. Open Access Maced J Med Sci. 2016;4(3):526–32.
12. Vin hquốc lu'o'ng K, Nguyễn LT. The beneficial role of vitamin D in obesity: Possible genetic and cell signaling mechanisms. Nutr J. 2013;12:89.
13. Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr. 2012;108(11):1915–23.
14. Larsen SC, Ängquist L, Moldovan M, Huikari V, Sebert S, Cavadino A, Ahluwalia TS, Skaaby T, Linneberg A, Husemoen LL, Toft U, Pedersen O, Hansen T, Herzig KH, Jarvelin MR, Power C, Hyppönen E, Heitmann BL, Sørensen TI. Serum 25-hydroxyvitamin D status and longitudinal changes in weight and waist circumference: Influence of genetic predisposition to adiposity. PLoS One. 2016;11(4):e0153611.
15. Webb AR, Holick MF. The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr. 1988;8:375–99.
16. Wacker M, Holick MF. Sunlight and vitamin D: A global perspective for health. Dermatoendocrinol. 2013;5(1):51–108.
17. Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism. 2006;55(4):515–24.
18. Petersen L, Schnohr P, Sørensen TI. Longitudinal study of the long-term relation between physical activity and obesity in adults. Int J Obes Relat Metab Disord. 2004;28(1):105–12.
19. Looker AC. Do body fat and exercise modulate vitamin D status? Nutr Rev. 2007;65(8 Pt 2):S124–6.
20. Vanlint S. Vitamin D and obesity. Nutrients. 2013;5(3):949–56.
21. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3.
22. Barrea L, Savastano S, Di Somma C, Savanelli MC, Nappi F, Albanese L, Orio F, Colao A. Low serum vitamin D-status, air pollution and obesity: A dangerous liaison. Rev Endocr Metab Disord. 2016; doi:10.1007/s11154-016-9388-6.
23. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci. 1972;43(3):413–31.
24. Lawson DE, Douglas J, Lean M, Sedrani S. Estimation of vitamin D3 and 25-hydroxyvitamin D3 in muscle and adipose tissue of rats and man. Clin Chim Acta. 1986;157(2):175–81.
25. Brouwer DA, van Beek J, Ferwerda H, Brugman AM, van der Klis FR, van der Heiden HJ, Muskiet FA. Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose. Br J Nutr. 1998;79(6):527–32.
26. Malmberg P, Karlsson T, Svensson H, Lönn M, Carlsson NG, Sandberg AS, Jennische E, Osmancevic A, Holmäng A. A new approach to measuring vitamin D in human adipose tissue using time-of-flight secondary ion mass spectrometry: A pilot study. J Photochem Photobiol B. 2014;138:295–301.
27. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab. 2011;96(3):E447–52.
28. Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20(7):1444–8.
29. 3 supplementation among obese adults. J Clin Endocrinol Metab. 2013;98(12):4845–51.
30. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: Mechanisms and implications. J Am Coll Nutr. 2002;21(2):146S–51S.
31. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr. 2007;27:79–101.
32. Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984;74(4):1540–4.
33. Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J. Vitamin D supplementation and body weight status: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2014;15(6):528–37.
34. Crujeiras AB, Carreira MC, Cabia B, Andrade S, Amil M, Casanueva FF. Leptin resistance in obesity: An epigenetic landscape. Life Sci. 2015;140:57–63.
35. Abbas MA. Physiological functions of vitamin D in adipose tissue. J Steroid Biochem Mol Biol. 2016; doi:10.1016/j.jsbmb.2016.08.004.
36. Kong J, Chen Y, Zhu G, Zhao Q, Li YC. 1,25-dihydroxyvitamin D3 upregulates leptin expression in mouse adipose tissue. J Endocrinol. 2013;216:265–71.
37. Nimitphong H, Holick MF, Fried SK, Lee MJ. 25-Hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 promote the differentiation of human subcutaneous preadipocytes. PLoS One. 2012;7(12):e52171.
38. Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901–10.
39. Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes. 2015;6(7):896–911.
40. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 2001;50(8):1844–50.
41. Elangovan H, Chahal S, Gunton JE. Vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta. 2017; doi:10.1016/j.bbadis.2017.01.001.
42. Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, Koteish AA, Clark JM, Guallar E, Hernaez R. Meta-analysis: Vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38(3):246–54.
43. Grammatiki M, Rapti E, Karras S, Ajjan RA, Kotsa K. Vitamin D and diabetes mellitus: Causal or casual association? Rev Endocr Metab Disord. 2017; doi:10.1007/s11154-016-9403-y.
44. Moore A, Hochner H, Sitlani CM, Williams MA, Hoofnagle AN, de Boer IH, Kestenbaum B, Siscovick DS, Friedlander Y, Enquobahrie DA. Plasma vitamin D is associated with fasting insulin and homeostatic model assessment of insulin resistance in young adult males, but not females, of the Jerusalem perinatal study. Public Health Nutr. 2015;18(7):1324–31.
45. Zhao G, Ford ES, Li C. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care. 2010;33(2):344–7.
46. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, Perkins BA, Harris SB, Zinman B, Hanley AJ. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33(6):1379–81.
47. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely prospective study 1990-2000. Diabetes. 2008;57(10):2619–25.
48. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med. 2010;267(5):462–72.
49. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in south Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2010;103(4):549–55.
50. Davidson MB. Response to comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260–266. Diabetes Care. 2013;36(5):e72.
51. De Pergola G, Nitti A, Bartolomeo N, Gesuita A, Giagulli VA, Triggiani V, Guastamacchia E, Silvestris F. Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients. Biomed Res Int. 2013;2013:921348.
52. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005;294(18):2336–41.
53. Teegarden D, Donkin SS. Vitamin D: Emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22(1):82–92.
54. Maestro B, Campión J, Dávila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000;47(4):383–91.
55. Demay MB. Mechanism of vitamin D receptor action. Ann N Y Acad Sci. 2006;1068:204–13.
56. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: The second decade. Cell. 1995;83(6):835–9.
57. Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK, Burgess JR, Teegarden D. 1alpha,25-dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol. 2008;112(1–3):122–6.
58. 3 receptor, modulating mammary epithelial cell growth. J Cell Biochem. 2011;112(11):3393–405.
59. 3 in modulating adipocyte apoptosis. FASEB J. 2004;18(12):1430–2.
60. Zemel MB, Sun X. Vitamin D modulation of adipocyte function M.F. Holick (Ed.), Vitamin D: Physiology, Molecular Biology and Clinical Applications, Humana Press Copyright Holder Springer Science Business Media, LLC. 2010; 345–357. doi: 10.1007/978-1-60327-303-9_17.
61. Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology. 2009;150(2):651–61.
62. Soares MJ, Chan She Ping-Delfos W, Ghanbari MH. Calcium and vitamin D for obesity: A review of randomized controlled trials. Eur J Clin Nutr. 2011;65(9):994–1004.
63. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3 T3-L1 cells. J Biol Chem. 2006;281(16):11205–13.
64. Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3 T3-L1 cells. Am J Physiol Endocrinol Metab. 2006;290(5):E916–24.
65. de Paula FJ, Dick-de-Paula I, Bornstein S, Rostama B, Le P, Lotinun S, Baron R, Rosen CJ. VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner. Calcif Tissue Int. 2011;89(3):179–91.
66. Weber K, Erben RG. Differences in triglyceride and cholesterol metabolism and resistance to obesity in male and female vitamin D receptor knockout mice. J Anim Physiol Anim Nutr (Berl). 2013;97(4):675–83.
67. Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur SV, Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol. 2013;228(10):2024–36.
68. Sun X, Morris KL, Zemel MB. Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: A microarray study. J Nutrigenet Nutrigenomics. 2008;1(1–2):30–48.
69. Ochs-Balcom HM, Chennamaneni R, Millen AE, Shields PG, Marian C, Trevisan M, Freudenheim JL. Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr. 2011;93(1):5–10.
70. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1α,25-dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J. 2001;15(14):2751–3.
71. Sergeev IN. 1,25-dihydroxyvitamin D3 induces Ca2 + −mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem Biophys Res Commun. 2009;384(1):18–21.
72. Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, Richelsen B, Pedersen SB. Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss. Int J Obes. 2013;37(5):651–7.
73. Stokić E, Kupusinac A, Tomic-Naglic D, Smiljenic D, Kovacev-Zavisic B, Srdic-Galic B, Soskic S, Isenovic ER. Vitamin D and dysfunctional adipose tissue in obesity. Angiology. 2015;66(7):613–8.
74. Stokić E, Kupusinac A, Tomić-Naglić D, Zavišić BK, Mitrović M, Smiljenić D, Soskić S, Isenović E. Obesity and vitamin D deficiency: Trends to promote a more proatherogenic cardiometabolic risk profile. Angiology. 2015;66(3):237–43.
75. Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R, Sbraccia P. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med. 2013;8(1):33–40.
76. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93(1):1–21.
77. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112(12):1785–8.
78. Foss YJ. Vitamin D deficiency is the cause of common obesity. Med Hypotheses. 2009;72(3):314–21.
79. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW, Hunink MG. Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med. 2010;170(1):27–40.
80. van Dijk SB, Takken T, Prinsen EC, Wittink H. Different anthropometric adiposity measures and their association with cardiovascular disease risk factors: A meta-analysis. Neth Hear J. 2012;20(5):208–18.
81. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.
82. Rodríguez-Rodríguez E, Navia B, López-Sobaler AM, Ortega RM. Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity (Silver Spring). 2009;17(4):778–82.
83. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008;7:4.
84. Kotler DP, Burastero S, Wang J, Pierson Jr RN. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: Effects of race, sex, and disease. Am J Clin Nutr. 1996;64(3):489S–97S.
85. Xu L, Cheng X, Wang J, Cao Q, Sato T, Wang M, Zhao X, Liang W. Comparisons of body-composition prediction accuracy: A study of 2 bioelectric impedance consumer devices in healthy Chinese persons using DXA and MRI as criteria methods. J Clin Densitom. 2011;14(4):458–64.
86. Kang SH, Cho KH, Park JW, Yoon KW, Do JY. Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population: Analysis using multi-frequency bioimpedance. Kidney Blood Press Res. 2015;40(3):223–30.
87. Bi X, Tey SL, Leong C, Quek R, Henry CJ. Prevalence of vitamin D deficiency in Singapore: its implications to cardiovascular risk factors. PLoS One. 2016;11(1):e0147616.
88. Kim YJ, Park JW, Kim JW, Park CS, Gonzalez JP, Lee SH, Kim KG, Oh JH. Computerized automated quantification of subcutaneous and visceral adipose tissue from computed tomography scans: Development and validation study. JMIR Med Inform. 2016;4(1):e2.
89. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M, Norris JM. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab. 2009;94(9):3306–13.
90. Lenders CM, Feldman HA, Von Scheven E, Merewood A, Sweeney C, Wilson DM, Lee PD, Abrams SH, Gitelman SE, Wertz MS, Klish WJ, Taylor GA, Chen TC. Holick MF; Elizabeth Glaser pediatric research network obesity study group. Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr. 2009;90(3):459–67.
91. Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009;94(1):67–73.
92. Sulistyoningrum DC, Green TJ, Lear SA, Devlin AM. Ethnic-specific differences in vitamin D status is associated with adiposity. PLoS One. 2012;7(8):e43159.
93. Rosenblum JL, Castro VM, Moore CE, Kaplan LM. Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr. 2012;95(1):101–8.
94. Mensink GB, Fletcher R, Gurinovic M, Huybrechts I, Lafay L, Serra-Majem L, Szponar L, Tetens I, Verkaik-Kloosterman J, Baka A, Stephen AM. Mapping low intake of micronutrients across Europe. Br J Nutr. 2013;110(4):755–73.
95. Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, Chope G, Hyppönen E, Berry J, Vieth R, Lanham-New S. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: A systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–64.
96. Belenchia AM, Tosh AK, Hillman LS, Peterson CA. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: A randomized controlled trial. Am J Clin Nutr. 2013;97(4):774–81.
97. Macdonald HM. Contributions of sunlight and diet to vitamin D status. Calcif Tissue Int. 2013;92(2):163–76.
98. Muscogiuri G, Altieri B, Annweiler C, Balercia G, Pal HB, Boucher BJ, Cannell JJ, Foresta C, Grübler MR, Kotsa K, Mascitelli L, März W, Orio F, Pilz S, Tirabassi G, Colao A. Vitamin D and chronic diseases: The current state of the art. Arch Toxicol. 2016; doi:10.1007/s00204-016-1804-x.
99. Lentjes MA, Mulligan AA, Welch AA, Bhaniani A, Luben RN, Khaw KT. Contribution of cod liver oil-related nutrients (vitamins a, D, E and eicosapentaenoic acid and docosahexaenoic acid) to daily nutrient intake and their associations with plasma concentrations in the EPIC-Norfolk cohort. J Hum Nutr Diet. 2015;28(6):568–82.
100. Smutna M, Kruzikova K, Marsalek P, Kopriva V, Svobodova Z. Fish oil and cod liver as safe and healthy food supplements. Neuro Endocrinol Lett. 2009;30(1):156–62.
101. Bloomfield HE, Kane R, Koeller E, Greer N, MacDonald R, Wilt T. Benefits and harms of the mediterranean diet compared to other diets [Internet]. editors source Washington (DC): Department of Veterans Affairs (US); 2015. VA Evidence-based Synthesis Program Reports.
102. Castro-Quezada I, Román-Viñas B, Serra-Majem L. The Mediterranean diet and nutritional adequacy: A review. Nutrients. 2014;6(1):231–48.
103. Baggerly CA, Cuomo RE, French CB, Garland CF, Gorham ED, Grant WB, Heaney RP, Holick MF, Hollis BW, McDonnell SL, Pittaway M, Seaton P, Wagner CL, Wunsch A. Sunlight and vitamin D: Necessary for public health. J Am Coll Nutr. 2015;34(4):359–65.
104. 3 supplementation on body fat mass in healthy overweight and obese women. Nutr J. 2012;11:78.
105. Gallagher JC, Yalamanchili V, Smith LM. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol. 2013;136:195–200.
106. Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L, McTiernan A. Vitamin D3 supplementation during weight loss: A double-blind randomized controlled trial. Am J Clin Nutr. 2014;99(5):1015–25.
107. Roust LR, DiBaise JK. Nutrient deficiencies prior to bariatric surgery. Curr Opin Clin Nutr Metab Care. 2016; doi:10.1097/MCO.0000000000000352.
108. Bacci V, Silecchia G. Vitamin D status and supplementation in morbid obesity before and after bariatric surgery. Expert Rev Gastroenterol Hepatol. 2010;4(6):781–94.
109. Lanzarini E, Nogués X, Goday A, Benaiges D, de Ramón M, Villatoro M, Pera M, Grande L, Ramón JM. High-dose vitamin D supplementation is necessary after bariatric surgery: A prospective 2-year follow-up study. Obes Surg. 2015;25(9):1633–8.
110. Kim J, Brethauer S. ASMBS clinical issues committee; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee, position statement. Metabolic bone changes after bariatric surgery. Surg Obes Relat Dis. 2015;11(2):406–11.
111. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S. American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: Cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract. 2013;19(2):337–72.